| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in AVTX over the last quarter tilts toward selling: insiders offloaded a net 101,317 shares worth roughly $2.0M.
Classified under Biotechnology (Health Care sector), AVTX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 190.3K | - | - | |
| Other | 95.0K | - | - | |
| Other | 51.8K | $1.04M | - | |
| CFO | 39.9K | $651.7K | - | |
| Other | 37.0K | $725.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2017 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 120,435 | $0.66 | $79,184.39 | +0.8% | |
| Aug 21, 2017 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 219,792 | $0.60 | $132,260.19 | +1.4% | |
| Aug 16, 2017 | Armistice Capital, LLC56 | 10% Owner | Buy | 954,228 | $0.61 | $585,091.92 | +6.5% | |
| Jun 9, 2017 | Hacksell Uli | Director | Buy | 20,000 | $0.75 | $14,900.00 | New | |
| May 19, 2017 | Armistice Capital, LLC56 | Director, 10% Owner | Buy | 72,672 | $0.63 | $45,783.36 | +2.2% | |
| May 11, 2017 | Armistice Capital, LLC56 | 10% Owner | Buy | 450,000 | $0.73 | $328,518.69 | +15.5% | |
| May 8, 2017 | Armistice Capital, LLC56 | 10% Owner | Buy | 2,592,858 | $0.49 | $1,277,942.22 | +420.1% | |
| Oct 20, 2015 | Marcus Ronald | Chief Medical Officer | Buy | 30,617 | $0.00 | - | +568.8% |